Cosmax BTI, Patent Related to Skin Condition Improvement

[Asia Economy Reporter Junho Hwang] Cosmax BTI announced on the 19th the acquisition of a patent right as a major management matter related to investment decisions.

The patent title is "Centella Asiatica-Derived Bacillus subtilis Strain and Its Use for Improving Skin Condition." The main content concerns the Centella Asiatica-derived Bacillus subtilis strain and its culture. The company stated, "The strain and its culture according to this invention have effects of skin moisturizing, skin barrier strengthening, skin regeneration, wound improvement, and skin inflammation improvement, making them useful for improving, preventing, or treating skin conditions."

The patent holders are Cosmax Co., Ltd. and one other person, with the acquisition date being October 19. The patent is expected to be used in future production products.